 |
|
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller
Clin Mol Hepatol. 2023;29(1):1-15. Published online 2022 Apr 15 DOI: https://doi.org/10.3350/cmh.2022.0017
|
|
Citations to this article as recorded by
 Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Do Seon Song, Jin Mo Yang, Young Kul Jung, Hyung Joon Yim, Hee Yeon Kim, Chang Wook Kim, Soon Sun Kim, Jae Youn Cheong, Hae Lim Lee, Sung Won Lee, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
Annals of Hepatology.2025; 30(1): 101749. CrossRef Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, Jinhang Gao, Xiangxin Kong, Zhaodi Che, Yangkun Guo, Hua Wang, Erdan Dong, Jia Xiao
Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Annals of Hepatology.2024; 29(1): 101162. CrossRef Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort
Joo Hyun Oh, Sang Bong Ahn, Seon Cho, Eun-Hee Nah, Eileen L. Yoon, Dae Won Jun
Journal of Hepatology.2024; 81(5): 772. CrossRef Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis
Min Woo Kang, Soon Kyu Lee, Eun Ji Jang, Jong Geun Park, Deok Hwa Seo, Ji Won Han, Jae Sung Yoo, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Liver Transplantation.2024; 30(9): 877. CrossRef Non-Invasive Biomarkers for Differentiating Alcohol Associated Hepatitis from Acute Decompensation in Patients with ALD
Mina Ignat, Horia Stefanescu
Journal of Clinical Medicine.2024; 13(13): 3747. CrossRef KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
Clinical and Molecular Hepatology.2024; 30(Suppl): S5. CrossRef The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study
Keungmo Yang, Sunghwan Kim, Hyun Yang, Sheng-Min Wang, Bumseok Jeong, Hyun Kook Lim, Si Hyun Bae
Clinical and Molecular Hepatology.2024; 30(4): 929. CrossRef Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease
Tamer A. Addissouky
Discover Medicine.2024;[Epub] CrossRef ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation
Li Song, Shuo Huang, Honghao Yan, Qing Ma, Qihan Luo, Jiang Qiu, Minxia Chen, Zongyuan Li, He Jiang, Yufan Chen, Fangming Chen, Yu Du, Haozhe Fu, Lisha Zhao, Kanglu Zhao, Ping Qiu
Frontiers in Pharmacology.2024;[Epub] CrossRef Current and future treatment for alcoholic‐related liver diseases
Eileen L. Yoon, Won Kim
Journal of Gastroenterology and Hepatology.2023; 38(8): 1218. CrossRef Alcohol consumption and the risk of liver disease: a nationwide, population-based study
Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
Frontiers in Medicine.2023;[Epub] CrossRef
|